Li, Jing
Huang, Chong-Bi
Zhao, Fan
Zhao, Dan-Dan
Ao, Meng-Yin
Zhang, Shao-Kai
Li, Zhi-Fang
Kang, Le-Ni
Qiao, You-Lin
Chen, Wen
Liu, Yin
Xu, Lian
Zeng, Xi
Yuan, Ming-Wei
Xue, Shao-Long
Liu, Shu-Yuan
Xi, Ming-Rong
Liao, Guang-Dong
Funding for this research was provided by:
Natural Science Foundation of China (82473145)
Yunnan Fundamental Research Projects (202201AS070059)
Article History
Received: 25 September 2025
Accepted: 4 December 2025
First Online: 16 December 2025
Declarations
:
: This study was conducted under compliance with the Declaration of Helsinki and was approved by the Clinical Trial Ethics Review Committee, West China Second University Hospital, Sichuan University (approval number: Q2017003); the Medical Ethics Committee of Henan Cancer Hospital (approval number: 2017009); and the Medical Ethics Committee of Changzhi Medical College (approval number: 2017002). The study was registered at the Chinese Clinical Trial Registry Center of the World Health Organization International Clinical Trials Registry Platform (Registration number ChiCRT2200055287). All participants provided written informed consent in every visits.
: Not applicable.
: The authors declare no competing interests.